- ►onlinejacc.org V Fuster, LE Ryden, RW Asinger, DS Cannom, … - Journal of the American College of Cardiology, 2001 - Elsevier The committee was composed of 8 members representing the ACC and AHA, 4
representing the ESC, 1 from the North American Society of Pacing and
Electrophysiology (NASPE), and a representative of the Johns Hopkins ... Cited by 1441 - Related articles - All 118 versions
- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 892 - Related articles - BL Direct - All 21 versions
- ►chestpubs.org DE Singer, AS Go - Clinics in geriatric medicine, 2001 - Elsevier Based solely on observational data, long-term anticoagulation has been a favored
therapy to prevent stroke in rheumatic AF. 47 It was unclear whether
anticoagulants would work in nonrheumatic AF or whether they would be ... Cited by 554 - Related articles - BL Direct - All 17 versions
- ►healthanddna.com [PDF] MK Higashi, DL Veenstra, LM Kondo, AK … - Jama, 2002 - Am Med Assoc Context Warfarin is a commonly used anticoagulant that requires careful clinical
management to balance the risks of overanticoagulation and bleeding with those
of underanticoagulation and clotting. The principal enzyme involved in ... Cited by 513 - Related articles - BL Direct - All 9 versions
- ►vcu.edu [PDF] PM Ridker, SZ Goldhaber, E Danielson, Y … - The New England journal of medicine, 2003 - nejm.highwire.org Results The trial was terminated early after 508 patients had undergone
randomization and had been followed for up to 4.3 years (mean, 2.1). Of 253
patients assigned to placebo, 37 had recurrent venous thromboembolism (7.2 ... Cited by 510 - Related articles - BL Direct - All 15 versions
J Ansell, J Hirsh, J Dalen, H Bussey, D … - Chest, 2001 - chestjournal.chestpubs.org Several important developments in the last 2 decades have improved clinical
outcomes with oral anticoagulation therapy and have led to an appropriate
increase in the use of this therapy by improving its safety. These ... Cited by 466 - Related articles - BL Direct - All 7 versions
RJ Beyth, LM Quinn, CS Landefeld - The American journal of medicine, 1998 - Elsevier PURPOSE: To evaluate the accuracy and clinical utility of the Outpatient
Bleeding Risk Index for estimating the probability of major bleeding in
outpatients treated with warfarin. The index was previously derived in a ... Cited by 346 - Related articles - BL Direct - All 9 versions
RJ Beyth, L Quinn, CS Landefeld - Ann Intern Med, 2000 - Am Coll Physicians Patients: 325 patients 65 years of age or older who started warfarin therapy
during hospitalization. Interventions: Patients were stratified according to
baseline risk for major bleeding and were randomly assigned to receive the ... Cited by 229 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] MC Fang, Y Chang, EM Hylek, J Rosand, SM … - Annals of internal medicine, 2004 - Am Coll Physicians Background: The risk for atrial fibrillation–associated stroke in- creases at
low anticoagulation intensities. However, higher inten- sities increase
hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires ... Cited by 229 - Related articles - BL Direct - All 8 versions
- ►annals.org [PDF] RG Hart, JL Halperin - Annals of internal medicine, 1999 - Am Coll Physicians Atrial fibrillation is associated with a sixfold increased risk for stroke. More
than a dozen published randomized trials of anticoagulants or antiplatelet
agents for stroke preven- tion provide solid evidence on which to base ... Cited by 220 - Related articles - BL Direct - All 5 versions
